Fresenius Medical Care Files 6-K for German Announcement

Ticker: FMCQF · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1333141

Fresenius Medical Care Ag 6-K Filing Summary
FieldDetail
CompanyFresenius Medical Care Ag (FMCQF)
Form Type6-K
Filed DateDec 12, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

Related Tickers: FMS

TL;DR

FMC filed a 6-K for a German announcement, no new US-specific info here.

AI Summary

Fresenius Medical Care AG filed a Form 6-K on December 12, 2024, to furnish a convenience translation of an announcement made pursuant to German Stock Corporation Act section 248a. The filing itself does not contain specific financial figures or operational details, but serves as a notification mechanism for the SEC regarding a public announcement made in Germany.

Why It Matters

This filing indicates Fresenius Medical Care is complying with regulatory disclosure requirements in both Germany and the US, ensuring transparency for investors regarding significant company announcements.

Risk Assessment

Risk Level: low — The filing is procedural and does not introduce new financial or operational risks.

Key Players & Entities

  • Fresenius Medical Care AG (company) — Registrant
  • December 12, 2024 (date) — Filing Date
  • section 248a of the German Stock Corporation Act (legal_document) — Basis for announcement

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to furnish a convenience translation of an announcement made by Fresenius Medical Care AG pursuant to section 248a of the German Stock Corporation Act.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed with the SEC on December 12, 2024.

Does this filing contain specific financial results for Fresenius Medical Care?

No, this filing is a report of a foreign private issuer and primarily serves to provide a translation of a German announcement, not to disclose new financial results.

What is the company's principal executive office address?

The company's principal executive offices are located at Else-Kröner Strasse 1, 61346 Bad Homburg, Germany.

Is Fresenius Medical Care required to file annual reports under Form 20-F?

Yes, the filing indicates that Fresenius Medical Care files or will file annual reports under cover of Form 20-F.

Filing Stats: 187 words · 1 min read · ~1 pages · Grade level 15.2 · Accepted 2024-12-12 06:00:38

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: December 12, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.